BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19432296)

  • 21. Neoadjuvant carboplatin before radiotherapy in stage IIA and IIB seminoma.
    Horwich A; Dearnaley DP; Sohaib A; Pennert K; Huddart RA
    Ann Oncol; 2013 Aug; 24(8):2104-7. PubMed ID: 23592702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG).
    Koutsoukos K; Tzannis K; Christodoulou C; Karavasilis V; Bakoyiannis C; Makatsoris T; Papandreou CN; Pectasides D; Dimopoulos MA; Bamias A
    World J Urol; 2016 Jun; 34(6):853-7. PubMed ID: 26410826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient?
    Dieckmann KP; Brüggeboes B; Pichlmeier U; Küster J; Müllerleile U; Bartels H
    Urology; 2000 Jan; 55(1):102-6. PubMed ID: 10654903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late relapse of stage i seminoma following single-agent carboplatin.
    Raj S; Williams MV; Dixon AK; Robson J; Mazhar D
    Oncology; 2007; 73(5-6):419-21. PubMed ID: 18515983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversies in the management of stage I seminoma: adjuvant carboplatin revisited.
    Aparicio J; Terrasa J;
    Clin Transl Oncol; 2019 Feb; 21(2):246-247. PubMed ID: 29992462
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjuvant carboplatin therapy in patients with clinical stage 1 testicular seminoma: is long-term morbidity increased?
    Ruf CG; Borck S; Anheuser P; Matthies C; Nestler T; Zecha H; Isbarn H; Dieckmann KP
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2335-2342. PubMed ID: 31286241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma.
    Aparicio J; García del Muro X; Maroto P; Paz-Ares L; Alba E; Sáenz A; Terrasa J; Barnadas A; Almenar D; Arranz JA; Sánchez M; Fernández A; Sastre J; Carles J; Dorca J; Gumà J; Yuste AL; Germà JR;
    Ann Oncol; 2003 Jun; 14(6):867-72. PubMed ID: 12796024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carboplatin in clinical stage I seminoma: too much and too little at the same time.
    Bosl GJ; Patil S
    J Clin Oncol; 2011 Mar; 29(8):949-52. PubMed ID: 21282532
    [No Abstract]   [Full Text] [Related]  

  • 29. Myths and facts on adjuvant carboplatin for stage I seminoma.
    Aparicio J; Germà JR
    J Clin Oncol; 2006 Jul; 24(21):e40. PubMed ID: 16849740
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone.
    Patterson H; Norman AR; Mitra SS; Nicholls J; Fisher C; Dearnaley DP; Horwich A; Mason MD; Huddart RA
    Radiother Oncol; 2001 Apr; 59(1):5-11. PubMed ID: 11295200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.
    Horwich A; Oliver RT; Wilkinson PM; Mead GM; Harland SJ; Cullen MH; Roberts JT; Fossa SD; Dearnaley DP; Lallemand E; Stenning SP;
    Br J Cancer; 2000 Dec; 83(12):1623-9. PubMed ID: 11104556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carboplatin for stage I seminoma.
    Gilligan T; Oh WK; Kantoff PW
    J Clin Oncol; 2006 Jun; 24(18):2971-2; author reply e32-3. PubMed ID: 16782940
    [No Abstract]   [Full Text] [Related]  

  • 33. [Radiotherapy of testicular seminoma: changes over the past 10 years].
    Mirimanoff RO
    Cancer Radiother; 2003 Nov; 7 Suppl 1():70s-77s. PubMed ID: 15124547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Stage I seminoma and radiotherapy: to bury it or not?].
    Pouessel D; Culine S; Azria D
    Cancer Radiother; 2008 Dec; 12(8):842-7. PubMed ID: 18760650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
    Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
    World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis.
    Powles T; Robinson D; Shamash J; Moller H; Tranter N; Oliver T
    Ann Oncol; 2008 Mar; 19(3):443-7. PubMed ID: 18048383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of early stage testicular seminoma.
    Classen J; Souchon R; Hehr T; Bamberg M
    J Cancer Res Clin Oncol; 2001 Aug; 127(8):475-81. PubMed ID: 11501746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treating IIA/B seminoma with combination carboplatin and radiotherapy.
    Gilbert DC; Vanas NJ; Beesley S; Bloomfield D; Money-Kyrle J; Norman A; Dearnaley D; Horwich A; Huddart RA
    J Clin Oncol; 2009 Apr; 27(12):2101-2; author reply 2102-3. PubMed ID: 19289608
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjuvant chemotherapy in stage I and stage II testicular cancer.
    Albers P; Perabo FG; Melchior D; Siener R
    World J Urol; 2001 Apr; 19(2):76-81. PubMed ID: 11374321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.
    Shepherd ST; Gillen G; Morrison P; Forte C; Macpherson IR; White JD; Mark PB
    Eur J Cancer; 2014 Mar; 50(5):944-52. PubMed ID: 24445148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.